MSN Pharmaceuticals clears USFDA audit

BL Hyderabad Bureau | | Updated on: Dec 21, 2021

USFDA approval will help MSN Pharma to deepen presence in US market

MSN Pharmaceuticals Inc, Piscataway, New Jersey, US, has successfully completed its maiden US Food and Drug Administration (USFDA) audit with zero observations.

MSN Labs launches generic drug for percutaneous coronary intervention

The company is a wholly-owned subsidiary of Hyderabad-based MSN Group of companies. The state-of-the-art finished dosages facility was established to bolster MSN Group’s product portfolio as well as contract development and manufacturing services, in the US and several other key regulatory markets.

Lilly signs two pacts with MSN Labs and Torrent Pharma, for Covid drug

MSN Pharma’s core strategy

“This is a major accomplishment for us. It augments the core strategy of establishing us as a preferred contract development and manufacturing service provider globally, offering end-to-end drug manufacturing services. Also, besides helping us to deepen our presence in the US market, it will enable us to make high-quality generics affordable, and accessible to patients swiftly and efficiently,” MSN said in a statement here on Tuesday.

Published on December 21, 2021
This article is closed for comments.
Please Email the Editor

You May Also Like

Recommended for you